Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Parkinson's Disease
100%
Parkinson
39%
DNA Extraction
38%
Platform Trials
32%
Levodopa-induced Dyskinesia
32%
Mild Cognitive Impairment
32%
Randomized Evaluation
32%
African Ancestry
32%
COVID-19
32%
Idiopathic Parkinson's Disease
32%
Stool
27%
Biobank
25%
Apolipoprotein L1 (APOL1)
24%
DNA Yield
21%
Method Validation
21%
Machine Learning
21%
Kidney Disease
21%
Risk Factors
20%
Clinical Data
20%
Polygenic Risk Score
20%
Fitness for Purpose
18%
Luxembourgish
18%
Clinical Outcomes
18%
High-risk Human Papillomavirus (HR-HPV)
17%
Usual Care
17%
GBA1
17%
Genetic Variants
17%
Odds Ratio
17%
Preanalytical Phase
16%
Fixed Tissue
16%
Baricitinib
16%
Disease Effects
16%
Convalescent Plasma
16%
Cardiovascular History
16%
Prognostic Analysis
16%
Risk Variant
16%
RNAlater
16%
Sample Stability
16%
Human Stool Samples
16%
Stabilizing Solution
16%
Urological Diseases
16%
Disease Duration
16%
Dopaminergic Pathway
16%
Long-read Sequencing
16%
Method Optimization
16%
Fecal Sample Collection
16%
Faecal DNA Extraction
16%
Cross-cohort
16%
Authorship Criteria
16%
Outcome Prediction
16%
Gait Data
16%
Metabolomics Data
16%
Clinical Decision Support Tool
16%
Clinical Biobank
16%
Peripheral Whole Blood
16%
Meta-analysis
16%
Memory Impairment
16%
Kidney Failure
16%
Health Effects
16%
Major Determinants
16%
Transcriptome Analysis
16%
Genome Sequence Analysis
16%
Cryopreservation
16%
Post-COVID
16%
Microbiological Analysis
16%
RNA Stabilizers
16%
Aging Effect
16%
Polygenic Background
16%
Neutral Buffered Formalin
16%
Cardiovascular Risk
16%
Metal-organic
16%
Xanthine Metabolism
16%
DNA Purity
16%
Predictors of Cognitive Impairment
16%
Ice Recrystallization Inhibition
16%
Idiopathic PD
16%
Gut Microbiota
16%
Sickle Cell Disease
16%
Induced Pluripotent Stem Cells (iPSCs)
16%
Variant Carriers
16%
Major Risk
16%
Circular RNA
16%
Age of Onset
16%
Centrifugal Concentration
16%
Cross-sectional Observational Study
16%
Clinical Phenotype
16%
Cardiac Arrest
16%
Functional Analysis
16%
Biospecimens
16%
DNA Quality
15%
No Significant Difference
14%
Estimated Glomerular Filtration Rate
12%
95% Confidence Interval
12%
Reactive Inhibition
10%
Magnetic Separation
10%
Stool Collection
10%
DNA Concentration
10%
Stabilizer
10%
Microbiome
10%
Supernatant
10%
Medicine and Dentistry
COVID-19
82%
Parkinson's Disease
82%
COVID-19 Therapy
65%
Gait
37%
Human Immunodeficiency Virus
32%
Metabolomics
32%
Formaldehyde
28%
Nephropathy
26%
Artificial Respiration
22%
Odds Ratio
19%
Gut Microbiome
16%
Care Group
16%
Renal Failure
16%
Drug Megadose
16%
Mild Cognitive Impairment
16%
Observational Study
16%
Staphylococcal Bacteremia
16%
Small Nucleolar RNA
16%
Tocilizumab
16%
Rifampicin
16%
Acetylsalicylic Acid
16%
Placebo
16%
Corticosteroid
16%
Genetics
16%
Education
16%
Dopamine
16%
Levodopa-Induced Dyskinesia
16%
Cardiovascular System
16%
Glomerular Filtration Rate
13%
Infection
13%
Comorbidity
13%
microRNA
11%
Staphylococcus Aureus
11%
Intention-to-Treat Analysis
11%
Hypoxia
11%
Medical Research
10%
Albuminuria
9%
Cardiovascular Disease
9%
Stereotypic Movement Disorder
8%
Diseases
7%
Unified Parkinson's Disease Rating Scale
7%
Levodopa
7%
Recurrent Disease
7%
Antibiotic Therapy
7%
Cross Sectional Study
6%
Severe Acute Respiratory Syndrome Coronavirus 2
6%
Cross-Validation
6%
Inflammation
6%
Logistic Regression Analysis
5%
Chronic Kidney Disease
5%